home / stock / khtrf / khtrf quote
Last: | $4.29 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $4.29 |
High: | $0 |
Low: | $0 |
Volume: | 2,200 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.29 | $0 | $4.29 | $0 | $0 | 2,200 | 07-17-2024 |
$4.29 | $4.29 | $4.29 | $4.29 | $4.29 | 5,300 | 07-16-2024 |
$4.18 | $0 | $4.18 | $0 | $0 | 3,800 | 07-15-2024 |
$4.18 | $4.18 | $4.18 | $4.18 | $4.18 | 3,250 | 07-12-2024 |
$4.21 | $4.2 | $4.21 | $4.21 | $4.2 | 10,900 | 07-11-2024 |
$4.1 | $0 | $4.1 | $0 | $0 | 2,100 | 07-10-2024 |
$4.1 | $0 | $4.1 | $0 | $0 | 7,800 | 07-09-2024 |
$4.1 | $0 | $4.1 | $0 | $0 | 4,500 | 07-08-2024 |
$4.1 | $4.1 | $4.1 | $4.1 | $4.1 | 9,600 | 07-02-2024 |
$4.15 | $4.17 | $4.15 | $4.1727 | $4.14 | 13,200 | 06-28-2024 |
$3.97 | $0 | $3.97 | $0 | $0 | 1,500 | 06-27-2024 |
$3.97 | $0 | $3.97 | $0 | $0 | 2,600 | 06-26-2024 |
$3.97 | $0 | $3.97 | $0 | $0 | 2,500 | 06-25-2024 |
$3.97 | $3.97 | $3.97 | $3.97 | $3.96 | 4,700 | 06-24-2024 |
$4.16 | $0 | $4.16 | $0 | $0 | 1,400 | 06-21-2024 |
$4.16 | $0 | $4.16 | $0 | $0 | 1,500 | 06-20-2024 |
$4.16 | $0 | $4.16 | $0 | $0 | 600 | 06-18-2024 |
$4.16 | $0 | $4.16 | $0 | $0 | 1,400 | 06-17-2024 |
$4.16 | $4.1422 | $4.16 | $4.16 | $4.1422 | 950 | 06-14-2024 |
$4.27 | $0 | $4.27 | $0 | $0 | 100 | 06-13-2024 |
News, Short Squeeze, Breakout and More Instantly...
Knight Therapeutics Inc Company Name:
KHTRF Stock Symbol:
OTCMKTS Market:
Knight Therapeutics Inc Website:
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has entered into an exclusive supply and distribution agreement with Ironshore Pharmaceuticals & Development, Inc., a wh...
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2024. All currency amounts are in ...
MONTREAL, May 07, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 2024 R...